← Back to Search

Radiation Therapy

VMAT for Brain Tumor

N/A
Waitlist Available
Led By Alan M Nichol, MD
Research Sponsored by British Columbia Cancer Agency
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new radiation technique called VMAT for patients with brain cancer that has spread. VMAT can treat the whole brain and give extra radiation to cancer spots at the same time. The goal is to see how well it works and what side effects it might have.

Eligible Conditions
  • Metastatic Brain Tumors

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Whole brain radiotherapyExperimental Treatment1 Intervention
whole brain radiotherapy (WBRT) and a simultaneous integrated boost (SIB) using volumetric modulated arc therapy

Find a Location

Who is running the clinical trial?

British Columbia Cancer AgencyLead Sponsor
176 Previous Clinical Trials
95,168 Total Patients Enrolled
Alan M Nichol, MDPrincipal InvestigatorBritish Columbia Cancer Agency
1 Previous Clinical Trials
1,514 Total Patients Enrolled

Media Library

Volumetric Modulated Arc Therapy (VMAT) (Radiation Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01046123 — N/A
~4 spots leftby Dec 2025